CorMedix Inc. Total Revenue

• CorMedix Inc. showed an increase of +617.0% in Total Revenue from 2024 to 2025.
• This data is from CorMedix Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
• XBRL data for this metric is available from 2012 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2013: $0.00 | Q2 2013: $0.00 | Q3 2013: $0.00 | Q1 2014: $12.2 thousand | Q2 2014: $39.7 thousand | Q3 2014: $52.4 thousand | Q1 2015: $31.00 | Q2 2015: $120.00 | Q3 2015: $36.00 | Q4 2015: $23.00 | Q1 2016: $41.4 thousand | Q2 2016: $16.5 thousand | Q3 2016: $44.5 thousand | Q4 2016: $121.00 | Q1 2017: $39.6 thousand | Q2 2017: $136.2 thousand | Q3 2017: $61.1 thousand | Q1 2018: $23.2 thousand | Q2 2018: $7.6 thousand | Q3 2018: $372.5 thousand | Q1 2019: $163.7 thousand | Q2 2019: $35.3 thousand | Q3 2019: $59.5 thousand | Q1 2020: $74.1 thousand | Q2 2020: $16.4 thousand | Q3 2020: $93.0 thousand | Q1 2021: $88.3 thousand | Q2 2021: $8.2 thousand | Q3 2021: $38.1 thousand | Q1 2022: $7.6 thousand | Q2 2022: $21.3 thousand | Q3 2022: $6.8 thousand | Q2 2024: $806.1 thousand | Q3 2024: $11.46 million | Q1 2025: $39.08 million | Q2 2025: $39.74 million | Q3 2025: $104.28 million.
• Historical annual values: Fiscal year 2025: $311.71 million | Fiscal year 2024: $43.47 million | Fiscal year 2022: $65.4 thousand | Fiscal year 2021: $190.9 thousand | Fiscal year 2020: $239.2 thousand | Fiscal year 2019: $283.3 thousand | Fiscal year 2018: $429.8 thousand | Fiscal year 2017: $329.3 thousand | Fiscal year 2016: $224.1 thousand | Fiscal year 2015: $210.1 thousand | Fiscal year 2014: $189.3 thousand | Fiscal year 2013: $2.0 thousand | Fiscal year 2012: $0.00.
• Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: August 8, 2026